Gossamer Bio Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Gossamer Bio, Inc. (GOSS) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents0.050.030.260.180.510.400.23
Short-Term Investments0.250.260.140.140.030.000.00
Cash & Short-Term Investments0.290.300.260.330.510.400.23
Accounts Receivable0.010.000.000.000.000.000.00
Inventory0.000.000.000.000.000.000.00
Other Current Assets0.010.010.010.010.010.000.00
Total Current Assets0.310.310.260.330.520.410.23
Non-Current Assets
Property, Plant & Equipment (Net)0.010.000.010.010.020.020.00
Other Non-Current Assets0.000.000.000.000.000.000.00
Total Non-Current Assets0.010.010.010.010.020.020.01
Total Assets0.320.310.270.340.540.430.24
Current Liabilities
Accounts Payable0.000.010.020.000.030.020.02
Short-Term Debt0.000.010.010.000.000.000.00
Current Portion of Long-Term Debt0.000.010.010.000.000.000.00
Accrued Liabilities0.020.020.020.020.030.000.00
Deferred Revenue0.020.000.000.000.000.000.00
Other Current Liabilities0.020.200.020.000.010.020.00
Total Current Liabilities0.050.050.050.040.040.040.02
Non-Current Liabilities
Long-Term Debt0.200.200.020.180.040.040.00
Other Non-Current Liabilities0.000.000.020.000.010.020.00
Total Non-Current Liabilities0.240.200.210.180.180.060.34
Total Liabilities0.290.250.260.220.220.070.36
Stockholders' Equity
Common Stock0.000.000.000.000.000.000.00
Retained Earnings-1.27-1.21-1.03-0.81-0.58-0.33-0.15
Accumulated Other Comprehensive Income0.000.000.000.000.000.000.00
Additional Paid-in Capital1.301.281.040.930.900.690.03
Shares Outstanding0.230.230.090.080.000.000.00
Total Stockholders' Equity0.030.060.010.120.320.35-0.12
Total Liabilities & Equity0.320.310.270.340.540.430.24